🔎 Trials Near Me

Akèy › Gliyoblastòm › Arizona › Phoenix

Etid klinik pou Gliyoblastòm nan Phoenix, AZ

8 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Ap rekriteFaz 1/2
  • Mayo Clinic Hospital in Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05432804

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Ap rekriteFaz 3
  • Mayo Clinic Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05902169

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • Mayo Clinic - Arizona, Phoenix
  • St. Joseph's Hospital and Medical Center, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

Ap rekriteFaz 1 bonè
  • St. Joseph's Hospital and Medical Center, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT07485049

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Ap rekrite
  • Mayo Clinic in Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07091864

A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients

Ap rekriteFaz 1/2
  • Mayo Clinic Hospital, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT07185880

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

Ap rekriteFaz 1 bonè
  • St. Joseph's Hospital and Medical Center, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Mar 6, 2026 · NCT07268053

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Ap rekriteFaz 1 bonè
  • St. Joseph's Hospital and Medical Center, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Nov 20, 2025 · NCT06072586

Etid Gliyoblastòm nan lòt vil

Lòt etid nan Phoenix

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.